ID   ELT2_CAEEL              Reviewed;         433 AA.
AC   Q10655; Q18371;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   18-JUN-2025, entry version 168.
DE   RecName: Full=Transcription factor elt-2 {ECO:0000305};
DE   AltName: Full=GATA-type domain-containing protein elt-2 {ECO:0000305};
GN   Name=elt-2 {ECO:0000312|WormBase:C33D3.1};
GN   ORFNames=C33D3.1 {ECO:0000312|WormBase:C33D3.1};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   DEVELOPMENTAL STAGE.
RC   STRAIN=Bristol N2;
RX   PubMed=7782329; DOI=10.1074/jbc.270.24.14666;
RA   Hawkins M.G., McGhee J.D.;
RT   "elt-2, a second GATA factor from the nematode Caenorhabditis elegans.";
RL   J. Biol. Chem. 270:14666-14671(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=9659934; DOI=10.1016/s0012-1606(98)80006-7;
RA   Fukushige T., Hawkins M.G., McGhee J.D.;
RT   "The GATA-factor elt-2 is essential for formation of the Caenorhabditis
RT   elegans intestine.";
RL   Dev. Biol. 198:286-302(1998).
RN   [4]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10518545; DOI=10.1073/pnas.96.21.11883;
RA   Fukushige T., Hendzel M.J., Bazett-Jones D.P., McGhee J.D.;
RT   "Direct visualization of the elt-2 gut-specific GATA factor binding to a
RT   target promoter inside the living Caenorhabditis elegans embryo.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:11883-11888(1999).
RN   [5]
RP   FUNCTION.
RX   PubMed=15733671; DOI=10.1016/j.ydbio.2004.12.012;
RA   Fukushige T., Goszczynski B., Yan J., McGhee J.D.;
RT   "Transcriptional control and patterning of the pho-1 gene, an essential
RT   acid phosphatase expressed in the C. elegans intestine.";
RL   Dev. Biol. 279:446-461(2005).
RN   [6]
RP   FUNCTION.
RX   PubMed=15734735; DOI=10.1074/jbc.m410928200;
RA   Oskouian B., Mendel J., Shocron E., Lee M.A. Jr., Fyrst H., Saba J.D.;
RT   "Regulation of sphingosine-1-phosphate lyase gene expression by members of
RT   the GATA family of transcription factors.";
RL   J. Biol. Chem. 280:18403-18410(2005).
RN   [7]
RP   INDUCTION BY P.AERUGINOSA.
RX   PubMed=16968778; DOI=10.1073/pnas.0603424103;
RA   Shapira M., Hamlin B.J., Rong J., Chen K., Ronen M., Tan M.W.;
RT   "A conserved role for a GATA transcription factor in regulating epithelial
RT   innate immune responses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:14086-14091(2006).
RN   [8]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17183709; DOI=10.1371/journal.pone.0000077;
RA   Kerry S., TeKippe M., Gaddis N.C., Aballay A.;
RT   "GATA transcription factor required for immunity to bacterial and fungal
RT   pathogens.";
RL   PLoS ONE 1:E77-E77(2006).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH LAG-1.
RX   PubMed=18003741; DOI=10.1242/dev.008680;
RA   Neves A., English K., Priess J.R.;
RT   "Notch-GATA synergy promotes endoderm-specific expression of ref-1 in C.
RT   elegans.";
RL   Development 134:4459-4468(2007).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=17113066; DOI=10.1016/j.ydbio.2006.10.024;
RA   McGhee J.D., Sleumer M.C., Bilenky M., Wong K., McKay S.J., Goszczynski B.,
RA   Tian H., Krich N.D., Khattra J., Holt R.A., Baillie D.L., Kohara Y.,
RA   Marra M.A., Jones S.J., Moerman D.G., Robertson A.G.;
RT   "The ELT-2 GATA-factor and the global regulation of transcription in the C.
RT   elegans intestine.";
RL   Dev. Biol. 302:627-645(2007).
RN   [11]
RP   FUNCTION.
RX   PubMed=17901115; DOI=10.1096/fj.06-7426com;
RA   Burmeister C., Luersen K., Heinick A., Hussein A., Domagalski M.,
RA   Walter R.D., Liebau E.;
RT   "Oxidative stress in Caenorhabditis elegans: protective effects of the
RT   Omega class glutathione transferase (GSTO-1).";
RL   FASEB J. 22:343-354(2008).
RN   [12]
RP   FUNCTION.
RX   PubMed=18024960; DOI=10.1074/jbc.m707043200;
RA   Romney S.J., Thacker C., Leibold E.A.;
RT   "An iron enhancer element in the FTN-1 gene directs iron-dependent
RT   expression in Caenorhabditis elegans intestine.";
RL   J. Biol. Chem. 283:716-725(2008).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH PHA-4.
RX   PubMed=18448117; DOI=10.1016/j.jmb.2007.11.103;
RA   Anokye-Danso F., Anyanful A., Sakube Y., Kagawa H.;
RT   "Transcription factors GATA/ELT-2 and forkhead/HNF-3/PHA-4 regulate the
RT   tropomyosin gene expression in the pharynx and intestine of Caenorhabditis
RT   elegans.";
RL   J. Mol. Biol. 379:201-211(2008).
RN   [14]
RP   FUNCTION.
RX   PubMed=19111532; DOI=10.1016/j.ydbio.2008.11.034;
RA   McGhee J.D., Fukushige T., Krause M.W., Minnema S.E., Goszczynski B.,
RA   Gaudet J., Kohara Y., Bossinger O., Zhao Y., Khattra J., Hirst M.,
RA   Jones S.J., Marra M.A., Ruzanov P., Warner A., Zapf R., Moerman D.G.,
RA   Kalb J.M.;
RT   "ELT-2 is the predominant transcription factor controlling differentiation
RT   and function of the C. elegans intestine, from embryo to adult.";
RL   Dev. Biol. 327:551-565(2009).
RN   [15]
RP   FUNCTION, DEVELOPMENTAL STAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=20807527; DOI=10.1016/j.ydbio.2010.08.020;
RA   Sommermann E.M., Strohmaier K.R., Maduro M.F., Rothman J.H.;
RT   "Endoderm development in Caenorhabditis elegans: the synergistic action of
RT   ELT-2 and -7 mediates the specification-differentiation transition.";
RL   Dev. Biol. 347:154-166(2010).
RN   [16]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20498281; DOI=10.1128/mcb.01459-09;
RA   Inoue H., Nishida E.;
RT   "The DM domain transcription factor MAB-3 regulates male hypersensitivity
RT   to oxidative stress in Caenorhabditis elegans.";
RL   Mol. Cell. Biol. 30:3453-3459(2010).
RN   [17]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=20164922; DOI=10.1038/nature08781;
RA   Raj A., Rifkin S.A., Andersen E., van Oudenaarden A.;
RT   "Variability in gene expression underlies incomplete penetrance.";
RL   Nature 463:913-918(2010).
RN   [18]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20126308; DOI=10.1371/journal.pone.0009010;
RA   Rohlfing A.K., Miteva Y., Hannenhalli S., Lamitina T.;
RT   "Genetic and physiological activation of osmosensitive gene expression
RT   mimics transcriptional signatures of pathogen infection in C. elegans.";
RL   PLoS ONE 5:E9010-E9010(2010).
RN   [19]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=21168435; DOI=10.1016/j.dci.2010.12.008;
RA   Elliott S.L., Sturgeon C.R., Travers D.M., Montgomery M.C.;
RT   "Mode of bacterial pathogenesis determines phenotype in elt-2 and elt-7
RT   RNAi Caenorhabditis elegans.";
RL   Dev. Comp. Immunol. 35:521-524(2011).
RN   [20]
RP   FUNCTION.
RX   PubMed=22194696; DOI=10.1371/journal.pgen.1002394;
RA   Romney S.J., Newman B.S., Thacker C., Leibold E.A.;
RT   "HIF-1 regulates iron homeostasis in Caenorhabditis elegans by activation
RT   and inhibition of genes involved in iron uptake and storage.";
RL   PLoS Genet. 7:E1002394-E1002394(2011).
RN   [21]
RP   FUNCTION.
RX   PubMed=22967128; DOI=10.1667/rr2989.1;
RA   Kimura T., Takanami T., Sakashita T., Wada S., Kobayashi Y.,
RA   Higashitani A.;
RT   "Innate immune genes including a mucin-like gene, mul-1, induced by
RT   ionizing radiation in Caenorhabditis elegans.";
RL   Radiat. Res. 178:313-320(2012).
RN   [22]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=23863485; DOI=10.1242/dev.098012;
RA   Nair G., Walton T., Murray J.I., Raj A.;
RT   "Gene transcription is coordinated with, but not dependent on, cell
RT   divisions during C. elegans embryonic fate specification.";
RL   Development 140:3385-3394(2013).
RN   [23]
RP   FUNCTION, SUBCELLULAR LOCATION, UBIQUITINATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23980181; DOI=10.1073/pnas.1311725110;
RA   Lee S.H., Wong R.R., Chin C.Y., Lim T.Y., Eng S.A., Kong C., Ijap N.A.,
RA   Lau M.S., Lim M.P., Gan Y.H., He F.L., Tan M.W., Nathan S.;
RT   "Burkholderia pseudomallei suppresses Caenorhabditis elegans immunity by
RT   specific degradation of a GATA transcription factor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:15067-15072(2013).
RN   [24]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=25284791; DOI=10.1016/j.celrep.2014.08.075;
RA   Schieber M., Chandel N.S.;
RT   "TOR signaling couples oxygen sensing to lifespan in C. elegans.";
RL   Cell Rep. 9:9-15(2014).
RN   [25]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=24834345; DOI=10.1186/2046-2395-3-5;
RA   Bansal A., Kwon E.S., Conte D. Jr., Liu H., Gilchrist M.J., MacNeil L.T.,
RA   Tissenbaum H.A.;
RT   "Transcriptional regulation of Caenorhabditis elegans FOXO/DAF-16 modulates
RT   lifespan.";
RL   Longev. Healthspan 3:5-5(2014).
RN   [26]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=25340560; DOI=10.1371/journal.pgen.1004609;
RA   Head B., Aballay A.;
RT   "Recovery from an acute infection in C. elegans requires the GATA
RT   transcription factor ELT-2.";
RL   PLoS Genet. 10:E1004609-E1004609(2014).
RN   [27]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=26700680; DOI=10.1242/dev.130914;
RA   Wiesenfahrt T., Berg J.Y., Nishimura E.O., Robinson A.G., Goszczynski B.,
RA   Lieb J.D., McGhee J.D.;
RT   "The Function and Regulation of the GATA Factor ELT-2 in the C. elegans
RT   Endoderm.";
RL   Development 143:483-491(2016).
RN   [28]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=25552416; DOI=10.1093/nar/gku1360;
RA   Roh H.C., Dimitrov I., Deshmukh K., Zhao G., Warnhoff K., Cabrera D.,
RA   Tsai W., Kornfeld K.;
RT   "A modular system of DNA enhancer elements mediates tissue-specific
RT   activation of transcription by high dietary zinc in C. elegans.";
RL   Nucleic Acids Res. 43:803-816(2015).
RN   [29]
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=26016853; DOI=10.1371/journal.pgen.1005265;
RA   Block D.H., Twumasi-Boateng K., Kang H.S., Carlisle J.A., Hanganu A.,
RA   Lai T.Y., Shapira M.;
RT   "The developmental intestinal regulator ELT-2 controls p38-dependent immune
RT   responses in adult C. elegans.";
RL   PLoS Genet. 11:E1005265-E1005265(2015).
RN   [30]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=26020930; DOI=10.1371/journal.pgen.1005268;
RA   Gordon K.L., Arthur R.K., Ruvinsky I.;
RT   "Phylum-level conservation of regulatory information in nematodes despite
RT   extensive non-coding sequence divergence.";
RL   PLoS Genet. 11:E1005268-E1005268(2015).
RN   [31] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=26963674; DOI=10.1016/j.ydbio.2016.02.031;
RA   Goszczynski B., Captan V.V., Danielson A.M., Lancaster B.R., McGhee J.D.;
RT   "A 44 bp intestine-specific hermaphrodite-specific enhancer from the C.
RT   elegans vit-2 vitellogenin gene is directly regulated by ELT-2, MAB-3, FKH-
RT   9 and DAF-16 and indirectly regulated by the germline, by daf-2/insulin
RT   signaling and by the TGF-beta/Sma/Mab pathway.";
RL   Dev. Biol. 413:112-127(2016).
RN   [32]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=26828939; DOI=10.1371/journal.pgen.1005823;
RA   Keith S.A., Maddux S.K., Zhong Y., Chinchankar M.N., Ferguson A.A.,
RA   Ghazi A., Fisher A.L.;
RT   "Graded proteasome dysfunction in Caenorhabditis elegans activates an
RT   adaptive response involving the conserved skn-1 and elt-2 transcription
RT   factors and the autophagy-lysosome pathway.";
RL   PLoS Genet. 12:E1005823-E1005823(2016).
RN   [33]
RP   FUNCTION, INTERACTION WITH RPT-6, SUBCELLULAR LOCATION, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=30265660; DOI=10.1371/journal.pgen.1007693;
RA   Olaitan A.O., Aballay A.;
RT   "Non-proteolytic activity of 19S proteasome subunit RPT-6 regulates GATA
RT   transcription during response to infection.";
RL   PLoS Genet. 14:E1007693-E1007693(2018).
CC   -!- FUNCTION: Transcriptional activator that binds to the consensus
CC       sequence 5'-[AT]GATA[AG]-3' (PubMed:15733671, PubMed:18003741,
CC       PubMed:18024960, PubMed:18448117, PubMed:26016853, PubMed:26700680,
CC       PubMed:26963674, PubMed:7782329). Predominantly directs the
CC       transcription of intestinal genes such as ges-1, cpr-6, pho-1, ftn-1,
CC       vit-2 and lev-11, and itself (PubMed:10518545, PubMed:15733671,
CC       PubMed:18448117, PubMed:19111532, PubMed:26700680, PubMed:26963674,
CC       PubMed:9659934). Required for gut-specific differentiation,
CC       specifically acting with the GATA region-binding transcription factor
CC       elt-7 to control normal gene expression and promote normal formation of
CC       the intestine (PubMed:20807527). Regulates intestinal gene expression
CC       in response to hypoxia to promote longevity (PubMed:25284791).
CC       Modulation of longevity may, in part, be the result of regulation of
CC       expression of daf-16 isoforms d and f in the intestine
CC       (PubMed:24834345). Regulates tissue specific gene expression at basal
CC       levels and in response to bacterial infection in the intestine to
CC       control innate immunity (PubMed:16968778, PubMed:21168435,
CC       PubMed:25340560, PubMed:26016853). Plays a role in the induction of
CC       metal-responsive genes, activating gene expression from zinc-activated
CC       promoters and iron-dependent promoters and enhancers (PubMed:18024960,
CC       PubMed:22194696, PubMed:25552416). May regulate the expression of genes
CC       that control sensitivity to oxidative stress, in a mab-3-dependent
CC       manner, and osmotic stress, in conjunction with the GATA region-binding
CC       transcription factor elt-3 (PubMed:17901115, PubMed:20126308,
CC       PubMed:20498281). May play a role in sphingolipid signaling by
CC       regulating the expression of the sphingosine-1-phosphate degrading
CC       enzyme, sphingosine-1-phosphate lyase (PubMed:15734735). May act with
CC       the Notch signaling pathway to promote endodermal gene expression
CC       (PubMed:18003741). Has a protective role in response to infection by
CC       Gram-negative bacteria such as S.enterica, E.coli, P.aeruginosa and
CC       B.pseudomallei, Gram-positive bacterium E.faecalis and fungal pathogen
CC       C.neoformans (PubMed:16968778, PubMed:17183709, PubMed:21168435,
CC       PubMed:23980181, PubMed:30265660). An association with the 26S
CC       proteasome regulatory subunit rpt-6, in part, controls gene expression
CC       in response to infection by P.aeruginosa (PubMed:30265660). Regulates
CC       gene expression during the recovery phase following a bacterial
CC       infection (PubMed:25340560, PubMed:30265660). May act with p38-
CC       activated transcription factors to control p38 gene induction in
CC       response to bacterial infection (PubMed:22967128, PubMed:26016853).
CC       Controls lysosome formation in the intestine by controlling lysosomal
CC       gene expression (PubMed:26828939). {ECO:0000269|PubMed:10518545,
CC       ECO:0000269|PubMed:15733671, ECO:0000269|PubMed:15734735,
CC       ECO:0000269|PubMed:16968778, ECO:0000269|PubMed:17183709,
CC       ECO:0000269|PubMed:17901115, ECO:0000269|PubMed:18003741,
CC       ECO:0000269|PubMed:18024960, ECO:0000269|PubMed:18448117,
CC       ECO:0000269|PubMed:19111532, ECO:0000269|PubMed:20126308,
CC       ECO:0000269|PubMed:20498281, ECO:0000269|PubMed:20807527,
CC       ECO:0000269|PubMed:21168435, ECO:0000269|PubMed:22194696,
CC       ECO:0000269|PubMed:22967128, ECO:0000269|PubMed:23980181,
CC       ECO:0000269|PubMed:25284791, ECO:0000269|PubMed:25340560,
CC       ECO:0000269|PubMed:26016853, ECO:0000269|PubMed:26700680,
CC       ECO:0000269|PubMed:26828939, ECO:0000269|PubMed:30265660,
CC       ECO:0000269|PubMed:7782329}.
CC   -!- SUBUNIT: Interacts with lag-1 (PubMed:18003741). Interacts with pha-4
CC       (PubMed:18448117). Interacts with rpt-6 (PubMed:30265660).
CC       {ECO:0000269|PubMed:18003741, ECO:0000269|PubMed:18448117,
CC       ECO:0000269|PubMed:30265660}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10518545,
CC       ECO:0000269|PubMed:23980181, ECO:0000269|PubMed:30265660,
CC       ECO:0000269|PubMed:7782329, ECO:0000269|PubMed:9659934}. Note=Expressed
CC       in discrete foci within nuclei of the gut in embryos.
CC       {ECO:0000269|PubMed:10518545}.
CC   -!- TISSUE SPECIFICITY: Expressed in the intestine.
CC       {ECO:0000269|PubMed:17113066, ECO:0000269|PubMed:26016853}.
CC   -!- DEVELOPMENTAL STAGE: Expressed at all stages but more highly during
CC       embryogenesis, with expression beginning at the 2E cell stage
CC       (endodermal stage). Expression continues to adulthood.
CC       {ECO:0000269|PubMed:10518545, ECO:0000269|PubMed:20164922,
CC       ECO:0000269|PubMed:20807527, ECO:0000269|PubMed:23863485,
CC       ECO:0000269|PubMed:26020930, ECO:0000269|PubMed:26700680,
CC       ECO:0000269|PubMed:7782329, ECO:0000269|PubMed:9659934}.
CC   -!- INDUCTION: By P.aeruginosa infection. {ECO:0000269|PubMed:16968778}.
CC   -!- PTM: May be ubiquitinated in response to infection by B.pseudomallei.
CC       {ECO:0000269|PubMed:23980181}.
CC   -!- DISRUPTION PHENOTYPE: Animals do not survive for long beyond hatching
CC       and frequently die at the L1 larval stage (PubMed:20807527,
CC       PubMed:9659934). Upon attempts to feed, food accumulates behind the
CC       pharynx and there is blockage of the brush border that surrounds the
CC       gut lumen in surviving L1 stage larvae (PubMed:20807527,
CC       PubMed:9659934). RNAi-mediated knockdown results in a reduced body size
CC       and reduced gene expression from zinc-activated promoters and of genes
CC       related to the immune response (PubMed:25552416, PubMed:26016853). This
CC       reduction in target gene expression is enhanced when infected with
CC       B.pseudomallei (PubMed:23980181). RNAi-mediated knockdown results in
CC       increased sensitivity and mortality when exposed to Gram-negative
CC       bacteria such as S.enterica, E.coli, P.aeruginosa and B.pseudomallei,
CC       Gram-positive bacterium E.faecalis and fungal pathogen C.neoformans
CC       (PubMed:16968778, PubMed:17183709, PubMed:21168435, PubMed:23980181,
CC       PubMed:30265660). Furthermore, when exposed to E.coli and P.aeruginosa,
CC       the intestines distend due to the colonization and proliferation of its
CC       bacterial content (PubMed:16968778, PubMed:17183709, PubMed:21168435).
CC       RNAi-mediated knockdown at the L4 larval stage, in addition, prevents
CC       the recovery of P.aeruginosa infected animals treated with the
CC       antibiotic streptomycin (PubMed:30265660). RNAi-mediated knockdown also
CC       results in increased sensitivity to heat and to arsenite- and paraquat-
CC       induced oxidative stress (PubMed:16968778, PubMed:20498281). RNAi-
CC       mediated knockdown results in fewer intestinal lysosomes
CC       (PubMed:26828939). RNAi-mediated knockdown during larval development
CC       results in smaller animals (PubMed:26016853). RNAi-mediated knockdown
CC       specifically during the L4 larval stage inhibits the expression of
CC       intestinal genes such as gsto-1, which is normally induced under
CC       hypoxic conditions, prevents increased longevity induced by transient
CC       hypoxia exposure and prevents mitohormesis when exposed to the
CC       mitochondrial reactive oxygen species-generating agent paraquat
CC       (PubMed:25284791). In addition, RNAi-mediated knockdown at this stage
CC       prevents the expression of genes that are usually up-regulated during
CC       recovery in response to tetracycline or kanamycin treatment following
CC       an infection and furthermore, prevents the recovery of S.enterica
CC       infected animals treated with tetracycline (PubMed:25340560). RNAi-
CC       mediated knockdown on an elt-3 knockout background results in increased
CC       sensitivity to osmotic stress (PubMed:20126308). Double mutation with
CC       elt-7 results in arrest at the L1 stage of larval development, reduced
CC       expression of gut-specific genes and a severe disruption to normal gut
CC       differentiation with the absence of birefringent and rhabditin
CC       granules, which are characteristic of normal gut differentiation,
CC       largely at the regions of the cell that interface with the pharyngeal
CC       and rectal valves (PubMed:20807527). These mutants also have
CC       essentially no gut lumen, with the infrequent occurance of patches of
CC       lumen and brush border in few animals, and reduced gut
CC       epithelialization as indicated by reduced expression of epithelial
CC       markers erm-1b, itx-1 and ajm-1 (PubMed:20807527). RNAi-mediated
CC       knockdown specifically during the L4 larval stage reduces the
CC       expression of daf-16 isoforms d and f, but has little or effect on
CC       isoform a. {ECO:0000269|PubMed:16968778, ECO:0000269|PubMed:17183709,
CC       ECO:0000269|PubMed:20126308, ECO:0000269|PubMed:20498281,
CC       ECO:0000269|PubMed:20807527, ECO:0000269|PubMed:21168435,
CC       ECO:0000269|PubMed:23980181, ECO:0000269|PubMed:24834345,
CC       ECO:0000269|PubMed:25284791, ECO:0000269|PubMed:25340560,
CC       ECO:0000269|PubMed:25552416, ECO:0000269|PubMed:26016853,
CC       ECO:0000269|PubMed:26828939, ECO:0000269|PubMed:30265660,
CC       ECO:0000269|PubMed:9659934}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U25175; AAC36130.1; -; Genomic_DNA.
DR   EMBL; BX284606; CAA90029.2; -; Genomic_DNA.
DR   PIR; A56953; A56953.
DR   PIR; T19677; T19677.
DR   RefSeq; NP_509755.2; NM_077354.4.
DR   AlphaFoldDB; Q10655; -.
DR   SMR; Q10655; -.
DR   BioGRID; 46163; 18.
DR   FunCoup; Q10655; 243.
DR   IntAct; Q10655; 2.
DR   STRING; 6239.C33D3.1.1; -.
DR   iPTMnet; Q10655; -.
DR   PaxDb; 6239-C33D3.1; -.
DR   PeptideAtlas; Q10655; -.
DR   EnsemblMetazoa; C33D3.1.1; C33D3.1.1; WBGene00001250.
DR   GeneID; 181250; -.
DR   KEGG; cel:CELE_C33D3.1; -.
DR   UCSC; C33D3.1; c. elegans.
DR   AGR; WB:WBGene00001250; -.
DR   CTD; 181250; -.
DR   WormBase; C33D3.1; CE31430; WBGene00001250; elt-2.
DR   eggNOG; KOG1601; Eukaryota.
DR   GeneTree; ENSGT00970000196325; -.
DR   HOGENOM; CLU_644427_0_0_1; -.
DR   InParanoid; Q10655; -.
DR   OMA; NIQVHVM; -.
DR   OrthoDB; 515401at2759; -.
DR   Reactome; R-CEL-5683826; Surfactant metabolism.
DR   Reactome; R-CEL-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   PRO; PR:Q10655; -.
DR   Proteomes; UP000001940; Chromosome X.
DR   Bgee; WBGene00001250; Expressed in E lineage cell (C elegans) and 18 other cell types or tissues.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IMP:WormBase.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IDA:WormBase.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:WormBase.
DR   GO; GO:0004857; F:enzyme inhibitor activity; IDA:WormBase.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; IDA:WormBase.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0045165; P:cell fate commitment; IBA:GO_Central.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IMP:UniProtKB.
DR   GO; GO:0008340; P:determination of adult lifespan; IMP:UniProtKB.
DR   GO; GO:0007586; P:digestion; IMP:WormBase.
DR   GO; GO:0007492; P:endoderm development; IMP:WormBase.
DR   GO; GO:0045087; P:innate immune response; IMP:WormBase.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0002119; P:nematode larval development; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:WormBase.
DR   GO; GO:0030856; P:regulation of epithelial cell differentiation; IMP:WormBase.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:UniProtKB.
DR   CDD; cd00202; ZnF_GATA; 1.
DR   FunFam; 3.30.50.10:FF:000032; Transcription factor GATA-3; 1.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   InterPro; IPR039355; Transcription_factor_GATA.
DR   InterPro; IPR000679; Znf_GATA.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR10071:SF281; BOX A-BINDING FACTOR-RELATED; 1.
DR   PANTHER; PTHR10071; TRANSCRIPTION FACTOR GATA FAMILY MEMBER; 1.
DR   Pfam; PF00320; GATA; 1.
DR   PRINTS; PR00619; GATAZNFINGER.
DR   SMART; SM00401; ZnF_GATA; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   PROSITE; PS00344; GATA_ZN_FINGER_1; 1.
DR   PROSITE; PS50114; GATA_ZN_FINGER_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Differentiation; DNA-binding; Metal-binding; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..433
FT                   /note="Transcription factor elt-2"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000083472"
FT   ZN_FING         237..261
FT                   /note="GATA-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00094"
FT   REGION          1..47
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          194..235
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          275..332
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        27..43
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        211..234
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        310..324
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   433 AA;  47116 MW;  59C2DEB0753E5499 CRC64;
     MDNNYNDNVN GWAEMEPSQP MGGLRLPTQN MDPPEQNNES QLSELPRMKI DNDYASPIER
     QSVITSGTNN YEPKVETVTS FFHTGIDYSN FGMLDQTTMQ PFYPLYSGIP VNTLGTFSGY
     TNSIYDKPSL YDPSIPTINI PSTYPTVAPT YECVKCSQSC GAGMKAVNGG MMCVNCSTPK
     TTYSPPVAYS TSLGQPPILE IPSEQPTAKI AKQSSKKSSS SNRGSNGSAS RRQGLVCSNC
     NGTNTTLWRR NAEGDPVCNA CGLYFKLHHI PRPTSMKKEG ALQTRKRKSK SGDSSTPSTS
     RARERKFERA SSSTEKAQRS SNRRAGSAKA DRELSTAAVA AATATYVSHA DLYPVSSAAV
     TLPDQTYSNY YQWNTAATAG LMMVPNDQNY VYAATNYQTG LRPADNIQVH VMPVQDDETK
     AAARDLEAVD GDS
//
